Apollo Hospitals elevates three leaders as hospitals chief exits
Key highlights
- Dr. Madhu Sasidhar will leave Apollo Hospitals at the close of business on November 14, 2026.
- Apollo Hospitals designated three executives as senior management personnel on November 4, 2026.
- Dr. Ritu Garg will oversee the North, Central, Western and Eastern regions.
- Anand Wasker and Dr. N. Venkatesan bring more than 26 years and 25 years of experience, respectively.
powered by IRIS

Apollo Hospitals Enterprise Limited said Dr. Madhu Sasidhar will cease as President and CEO of its Hospitals Division at the close of business on November 14, 2026, after completing his employment tenure, while the board designated three executives as senior management personnel for regional hospitals, international business and procurement.
Know Apollo Hospitals Enterprise inside out
Results, valuation, peers and who's buying, in one view.
Why is Apollo Hospitals’ hospitals chief leaving?
Dr. Madhu Sasidhar will cease to be President and CEO of the Hospitals Division and a designated senior management personnel of Apollo Hospitals on November 14, 2026. The company said the cessation takes effect at the close of business following the successful completion of his employment tenure.
Apollo Hospitals said there was no material reason for the cessation other than the completion of that tenure. Its November 4, 2026 disclosure did not identify a successor to the Hospitals Division President and CEO position or announce another reason for the management change.
During his tenure, Dr. Sasidhar made contributions to strengthening clinical-excellence practices and augmenting Apollo Hospitals’ digital-health capabilities, according to the company. Those were the two operating contributions specifically identified in the November 4 filing made under Regulation 30 of the Securities and Exchange Board of India, or SEBI, listing regulations.
Who has Apollo Hospitals elevated to senior management?
Apollo Hospitals designated Dr. Ritu Garg, Anand Wasker and Dr. N. Venkatesan as senior management personnel following a recommendation from its Nomination and Remuneration Committee. The board described the three designations as part of leadership-strengthening initiatives intended to provide seamless business continuity after the November 14 departure.
Dr. Garg is Chief Executive Officer, Multi Regions, covering the North, Central, Western and Eastern regions. Apollo Hospitals said she has more than two decades of healthcare experience across operations, growth, transformation and innovation, and holds MBBS, MS and Master of Business Administration degrees, with the latter in Finance and Strategy.
Mr. Wasker is Chief Business Officer, International, and has more than 26 years of leadership experience, according to Apollo Hospitals. The company said his experience spans healthcare, financial services, telecom, education, beauty and wellness consumer services, and that he holds a master’s degree in business management.
Dr. Venkatesan is Chief Procurement Officer and has more than 25 years of experience across healthcare procurement, supply chain, pharmacy operations, materials management, commercial functions and hospital project execution. Apollo Hospitals said he holds a Ph.D. in Hospital Supply Chain Management and a Master of Business Administration in Systems.
Got a follow-up? Ask IRIS
How will reporting lines change at Apollo Hospitals?
Support functions and other regions that previously reported to the President and CEO will report to the Project Management Office under the guidance of Apollo Hospitals’ Managing Director. The filing disclosed this structure alongside confirmation that Dr. Sasidhar’s Hospitals Division role ends at the close of business on November 14, 2026.
Apollo Hospitals did not identify the person leading the Project Management Office or name a successor to the Hospitals Division President and CEO role in its November 4 announcement. The reported arrangement changes the reporting route for support functions and other regions rather than setting out a direct replacement for the departing role.
The three newly designated senior managers have distinct mandates across four domestic regional groupings, international business and procurement. By comparison, the revised reporting line covers support functions and other regions that had previously been under the Hospitals Division chief, with the Project Management Office operating under the Managing Director’s guidance.
Apollo Hospitals did not disclose financial targets, operational milestones or a completion date for the revised reporting arrangement. Management described the designations and structure as measures for leadership strengthening and business continuity, without quantifying effects on hospital operations, digital health, procurement or international business.
What is the timetable for the Apollo Hospitals transition?
The transition has an effective date of November 14, 2026, 10 calendar days after Apollo Hospitals’ November 4 board-meeting disclosure. At that meeting, the board also approved unaudited standalone and consolidated financial results for the three and six months ended September 30, 2026.
The filing refers to Annexure B for the cessation details concerning Dr. Sasidhar and Annexure C for the senior-management designations. Apollo Hospitals said the disclosures were made under Regulation 30 and applicable SEBI circulars governing communication of material events by listed companies.
The filing distinguishes between the departure from a division-wide leadership post and appointments with territory- or function-specific remits. Dr. Garg covers four regions, while Mr. Wasker leads international business and Dr. Venkatesan leads procurement; support functions and other regions move to the Project Management Office.
Apollo Hospitals’ November 4 disclosure was signed by S. M. Krishnan, Senior Vice President, Finance and Company Secretary. It records that the board meeting began at 3.20 p.m. and concluded at 5.35 p.m., and says the announcement would be made available on the company website.
Conclusion
Apollo Hospitals has set out a Hospitals Division leadership transition in which Dr. Sasidhar will leave on November 14, 2026 after completing his employment tenure. Three executives have been designated as senior management personnel with regional, international and procurement mandates, while support functions and other regions will report through the Project Management Office under the Managing Director’s guidance.
The next disclosed milestone is Dr. Sasidhar’s cessation at the close of business on November 14, 2026. Apollo Hospitals has not named a successor to the Hospitals Division President and CEO role or provided a timetable or performance targets for the new reporting arrangement, leaving any further leadership appointment or operating update for a subsequent company disclosure.


